Table 1.
Patient Cohort n=107.
| Age (years) | Mean | SD |
| 49.04 | 15.26 | |
| Tumor size (mm) | Mean | SD |
| 19.95 | 10.33 | |
| Gender | N | percent |
| F | 62 | 58% |
| M | 45 | 42% |
| Intraoperative medial wall invasion | N | Percent |
| Negative | 57 | 53% |
| Positive | 50 | 47% |
| Histological medial wall invasion | N | Percent |
| Negative | 11 | 10.3% |
| Positive | 39 | 36.4% |
| "N/A" = Negative | 57 | 53.3% |
| Clinical.Syndrome | N | Percent |
| Functional | 55 | 51% |
| Non-functional | 52 | 49% |
| WHO 2017 Adenoma Classification | N | Percent |
| Corticotroph | 28 | 26% |
| Gonadotroph | 27 | 25% |
| Somatotroph | 24 | 22% |
| Lactotroph | 17 | 16% |
| Null cell | 5 | 5% |
| Plurihormonal | 6 | 9% |
| Knosp grade | N | Percent |
| Grade 0 | 28 | 26% |
| Grade 1 | 43 | 40% |
| Grade 2 | 18 | 17% |
| Grade 3A | 11 | 10% |
| Grade 3B | 5 | 5% |
| Grade 4 | 2 | 2% |
Cohort of 107 consecutive primary pituitary adenoma patients. Variables include age, tumor size, gender, intraoperative evaluation of medial wall invasion, histological evaluation of medial wall invasion, WHO 2017 Adenoma classification and Knosp grade. Categorical variables are reported as number and percentage, and continuous variables are reported as mean ± standard deviation.